MHO Q1 2026 Earnings EPS Beats Estimates Amid Solid Operational Performance Verastem Q1 2026 Earnings NarrowerthanExpected Loss Beats Estimates Stock Edges Higher HTBK Q4 2025 Earnings Slight EPS Miss Amid Stable Performance AQB Q3 2024 Earnings Narrowerthanexpected loss drives modest stock gain ATAI Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances IPHA Q1 2026 Earnings WiderThanExpected Losses on Zero Revenue